Physicians
Overview
Cellvizio system
Education
Reimbursement
GastroEnterology
Barrett’s Esophagus
Pancreatic Cysts
Gastric Disease
Inflammatory Bowel Diseases
Irritable Bowel Syndrome
Bilio-Pancreatic Strictures
Colorectal Lesions
Pulmonology
Lung Nodules
Covid-19
Urology
Investors
About us
Our story
Team
Board of Directors
Leadership
Join Us
Press Coverage
Commercial Network
News & events
US
INT
FR
US
INT
FR
Contact
Search
Search
News - Cellvizio
-
Dec 4, 2017
Mauna Kea Technologies Renews its Equity Financing Facility to Support its Development
Please download the official press release for full details
You might also like to read
NEWS - Cellvizio
Oct 31, 2022
Mauna Kea Technologies Announces Success of Clinical Trial on Prediction of Remission in Patients with Inflammatory Bowel Disease (IBD) and its Publication in Gastroenterology
Discover
NEWS - Cellvizio
Apr 12, 2022
Mauna Kea Technologies Announces First of Its Kind U.S. FDA 510(k) Clearance for Use of Cellvizio in a New Category of Molecular Imaging-guided Endoscopic, Laparoscopic, Needle-Based Procedures
Discover
NEWS - Cellvizio
Jul 11, 2022
Tasly Pharmaceuticals and Mauna Kea Technologies Announce Joint Venture and Licensing Agreements
Discover
